United Kingdom

People: Baxter International Inc (BAX.N)

BAX.N on New York Stock Exchange

19 Aug 2019
Change (% chg)

$0.90 (+1.03%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Wendell, Amy 

Ms. Amy A. Wendell is the Indepedent Director of the Company. Ms. Wendell is Senior Advisor at Perella Weinberg Partners L.P., consulting on strategy, corporate finance and investing practices in the healthcare industry, which she joined in 2016. She previously served as Senior Vice President of strategy and business development at Covidien from 2006 to 2015, where she led the company’s strategy and portfolio management initiatives and managed business development activities. From 1986 to 2015, Ms. Wendell held prior roles of increasing responsibility at Covidien (including its predecessors, Tyco International plc and Kendall Healthcare Products Company), from engineering to product management and business development. She serves as a director of Hologic, Inc. and Axogen, Inc .Extensive expertise in the healthcare section in the areas of global business development and licensing, portfolio management, mergers and acquisitions, resource allocation, and identifying new market opportunities, as a result of her roles at Covidien and its predecessors. She has significant restructuring and integration experience as well.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Jose Almeida


James Saccaro


Brian Stevens


Sean Martin


Jeanne Mason


Giuseppe Accogli

As Of  31 Dec 2018